Chemoimmunotherapy with fludarabine, cytoxan and rituximab regimen: to use, not to use, or give it as "FCR-LITE"?

Leuk Lymphoma. 2014 Apr;55(4):733-4. doi: 10.3109/10428194.2013.829575. Epub 2013 Sep 6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male